Karin Jirström
291 – 300 of 344
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients.
(
- Contribution to journal › Article
-
Mark
Immunohistochemical detection of tyrosine phosphatase SHP-1 predicts outcome after radical prostatectomy for localized prostate cancer.
(
- Contribution to journal › Article
-
Mark
Modeling Prognostic Markers in Breast Cancer — Are We Using Them the Optimal Way?
(
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer
(
- Contribution to journal › Article
-
Mark
Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer
(
- Contribution to journal › Article
-
Mark
Prognostic Significance of Stromal Platelet-Derived Growth Factor beta-Receptor Expression in Human Breast Cancer
(
- Contribution to journal › Article
-
Mark
Long-Term Survival of Breast Ductal Carcinoma In Situ in Women with Different Gene-Expression Types.
(
- Contribution to journal › Published meeting abstract
-
Mark
Vascular endothelial growth factor receptor 2 is a significant negative prognostic biomarker in triple-negative breast cancer: results from a controlled randomised trial of premenopausal breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
DEVELOPMENT OF IMMUNOHISTOCHEMICAL SURROGATES FOR PREDICTION OF BREAST CANCER PATIENT OUTCOME VIA HIGH-THROUGHPUT ANTIBODY GENERATION AND APPLICATION OF TISSUE MICROARRAY TECHNOLOGY: AN INITIAL REPORT
(
- Contribution to journal › Published meeting abstract
-
Mark
The Prognostic Significance of Tryptophanyl-tRNA Synthetase in Colorectal Cancer
(
- Contribution to journal › Article